SPY420.86+5.94 1.43%
DIA338.78+5.82 1.75%
IXIC14,141.48+111.10 0.79%

Axsome Therapeutics Q1 EPS $(0.78) Beats $(0.87) Estimate

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.87) by 10.34 percent. This is a 11.36 percent increase over losses of $(0.88) per share

05/10/2021 07:08
Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.87) by 10.34 percent. This is a 11.36 percent increase over losses of $(0.88) per share from the same period last year.